$BBLR
Bubblr Inc.

2024 Q3 Form 10-Q Financial Statement

#000149315224031989 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $1.415K $1.168K
YoY Change 22.94%
Cost Of Revenue $140.00 $389.00
YoY Change
Gross Profit $1.275K $779.00
YoY Change 10.77%
Gross Profit Margin 90.11% 66.7%
Selling, General & Admin $340.6K $315.4K $1.285M
YoY Change -69.29% -75.45% 2009.12%
% of Gross Profit 26712.94% 40484.34%
Research & Development $53.89K $49.77K $52.12K
YoY Change -10.02% -4.5% -1.09%
% of Gross Profit 4226.35% 6389.35%
Depreciation & Amortization $1.179K $2.513K $3.106K
YoY Change -99.33% -19.09%
% of Gross Profit 92.47% 322.59%
Operating Expenses $471.9K $717.3K $1.790M
YoY Change -61.86% -59.92% -27.91%
Operating Profit -$470.7K -$716.5K -$1.790M
YoY Change -61.92% -59.97% -27.91%
Interest Expense -$26.22K $29.44K $617.00
YoY Change -440.34% 4671.47% -97.97%
% of Operating Profit
Other Income/Expense, Net -$26.17K $42.03K $86.63K
YoY Change -140.32% -51.48% -30.06%
Pretax Income -$496.8K -$674.5K -$1.703M
YoY Change -57.58% -60.4% -27.8%
Income Tax
% Of Pretax Income
Net Earnings -$496.8K -$674.5K -$1.703M
YoY Change -57.58% -60.4% -27.8%
Net Earnings / Revenue -35112.23% -57748.37%
Basic Earnings Per Share $0.00 $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 159.7M shares 159.7M shares 156.3M shares
Diluted Shares Outstanding 159.7M shares 159.7M shares 156.3M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $720.00 $790.00
YoY Change -56.63%
Cash & Equivalents $717.00 $789.00 $5.507K
Short-Term Investments
Other Short-Term Assets $200.00 $200.00
YoY Change 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables $5.126K $5.785K $7.741K
Total Short-Term Assets $5.843K $6.574K $13.25K
YoY Change -45.66% -50.38% -90.52%
LONG-TERM ASSETS
Property, Plant & Equipment $901.00 $43.87K
YoY Change -97.95% -20.0%
Goodwill
YoY Change
Intangibles $1.115M $1.109M $1.284M
YoY Change -6.32% -13.62% 3947.05%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.115M $1.110M $1.328M
YoY Change -9.3% -16.4% -1.99%
TOTAL ASSETS
Total Short-Term Assets $5.843K $6.574K $13.25K
Total Long-Term Assets $1.115M $1.110M $1.328M
Total Assets $1.121M $1.117M $1.341M
YoY Change -9.62% -16.74% -10.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.3K $383.4K $194.0K
YoY Change 36.49% 97.6% 43.24%
Accrued Expenses $1.615M $1.333M $834.4K
YoY Change 22.63% 59.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $285.7K
YoY Change -100.0%
Total Short-Term Liabilities $2.015M $2.002M $1.795M
YoY Change -17.3% 11.53% 192.54%
LONG-TERM LIABILITIES
Long-Term Debt $970.4K $549.1K
YoY Change 82.14%
Other Long-Term Liabilities $45.54K $19.32K
YoY Change -45.46%
Total Long-Term Liabilities $1.016M $568.4K $757.4K
YoY Change 64.85% -24.95% -72.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.015M $2.002M $1.795M
Total Long-Term Liabilities $1.016M $568.4K $757.4K
Total Liabilities $3.031M $2.570M $2.552M
YoY Change -0.72% 0.7% -23.21%
SHAREHOLDERS EQUITY
Retained Earnings -$17.31M -$16.79M -$14.88M
YoY Change 7.72% 12.87% 26.13%
Common Stock $1.597M $1.597M $1.569M
YoY Change 1.58% 1.79% -0.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.910M -$1.453M -$1.211M
YoY Change
Total Liabilities & Shareholders Equity $1.121M $1.117M $1.341M
YoY Change -9.62% -16.74% -10.27%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$496.8K -$674.5K -$1.703M
YoY Change -57.58% -60.4% -27.8%
Depreciation, Depletion And Amortization $1.179K $2.513K $3.106K
YoY Change -99.33% -19.09%
Cash From Operating Activities -$83.00K -$12.85K
YoY Change -79.88%
INVESTING ACTIVITIES
Capital Expenditures $2.060K -$3.660K
YoY Change -90.61%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.060K -$13.30K
YoY Change -90.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 85.09K 43.85K
YoY Change -77.78%
NET CHANGE
Cash From Operating Activities -83.00K -12.85K
Cash From Investing Activities -2.060K -13.30K
Cash From Financing Activities 85.09K 43.85K
Net Change In Cash 30.00 17.70K
YoY Change -100.06%
FREE CASH FLOW
Cash From Operating Activities -$83.00K -$12.85K
Capital Expenditures $2.060K -$3.660K
Free Cash Flow -$85.06K -$9.190K
YoY Change -80.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
159690447 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1596904 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13386895 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16791489 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
354426 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1453263 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1116863 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
BBLR Forfeit Of Restricted Stock Units
ForfeitOfRestrictedStockUnits
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
BBLR Proceeds From Sale Of Fixed Assets
ProceedsFromSaleOfFixedAssets
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2024Q2 BBLR Research And Development Other Receivables
ResearchAndDevelopmentOtherReceivables
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
BBLR Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
BBLR Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
shares
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.01
CY2024Q2 us-gaap Cash
Cash
789 usd
CY2023Q4 us-gaap Cash
Cash
7668 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
5785 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
87503 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
6574 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
95171 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
901 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31302 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1109388 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1456628 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1110289 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1487930 usd
CY2024Q2 us-gaap Assets
Assets
1116863 usd
CY2023Q4 us-gaap Assets
Assets
1583101 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
383412 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
373606 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1332590 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
943007 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2001732 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1487471 usd
CY2024Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
19315 usd
CY2023Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
39116 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
568394 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
591755 usd
CY2024Q2 us-gaap Liabilities
Liabilities
2570126 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2079226 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159690447 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159690447 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1596904 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13168915 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15612775 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
350830 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-496125 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1583101 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1168 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2672 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
389 usd
us-gaap Cost Of Revenue
CostOfRevenue
1011 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
779 usd
us-gaap Gross Profit
GrossProfit
1661 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
321601 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1178987 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
631669 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1195276 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
45025 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
390304 usd
us-gaap Professional Fees
ProfessionalFees
53053 usd
us-gaap Professional Fees
ProfessionalFees
164734 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
-6228 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
105553 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11945 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
418016 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
307143 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
62882 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
361134 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
122509 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49773 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52119 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97638 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91271 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
717314 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1789845 usd
us-gaap Operating Expenses
OperatingExpenses
1155439 usd
us-gaap Operating Expenses
OperatingExpenses
1991806 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-716535 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1789845 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1153778 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1991806 usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
12569 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
15 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
14047 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
113 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2527 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
617 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
6119 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1746 usd
CY2024Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
24 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9331 usd
CY2024Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
21052 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
69988 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
19801 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2531 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
10916 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
17242 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
12 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
38417 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
42034 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
86628 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18410 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
34253 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-674501 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1703217 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1135368 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1957553 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-674501 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1703217 usd
us-gaap Net Income Loss
NetIncomeLoss
-1135368 usd
us-gaap Net Income Loss
NetIncomeLoss
-1957553 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40519 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-59661 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-40519 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-59661 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-674501 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1743736 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1135368 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2017214 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
155578988 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155578988 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
86277 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
285338 usd
CY2023Q1 BBLR Stock Issued During Period Value Forfeit Restrictive Stock Units
StockIssuedDuringPeriodValueForfeitRestrictiveStockUnits
-659052 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
22133 usd
CY2023Q1 BBLR Stock Issued During Period Value Preferred Shares Dividend
StockIssuedDuringPeriodValuePreferredSharesDividend
-21672 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-254336 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19142 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-560454 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
50000 usd
CY2023Q2 BBLR Stock Issued During Period Value Issued For Professional Services
StockIssuedDuringPeriodValueIssuedForProfessionalServices
65000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
21672 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
978410 usd
CY2023Q2 BBLR Stock Issued During Period Value Preferred Shares Dividend
StockIssuedDuringPeriodValuePreferredSharesDividend
-21672 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1703217 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-40519 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1210780 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-496125 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
108990 usd
CY2024Q1 BBLR Stock Issued During Period Value Preferred Shares Dividend
StockIssuedDuringPeriodValuePreferredSharesDividend
-21673 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-460867 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14476 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-855199 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-855199 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
108990 usd
CY2024Q2 BBLR Stock Issued During Period Value Preferred Shares Dividend
StockIssuedDuringPeriodValuePreferredSharesDividend
-21673 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-674501 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10880 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1453263 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1453263 usd
us-gaap Net Income Loss
NetIncomeLoss
-1135368 usd
us-gaap Net Income Loss
NetIncomeLoss
-1957553 usd
us-gaap Share Based Compensation
ShareBasedCompensation
400338 usd
BBLR Forfeit Of Restricted Stock Units
ForfeitOfRestrictedStockUnits
-659052 usd
BBLR Vesting Of Deferred Stock Based Compensation
VestingOfDeferredStockBasedCompensation
-217980 usd
BBLR Vesting Of Deferred Stock Based Compensation
VestingOfDeferredStockBasedCompensation
-978410 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
19801 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-2531 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9331 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
357176 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
116125 usd
us-gaap Depreciation
Depreciation
3958 usd
us-gaap Depreciation
Depreciation
6384 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-85196 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2537 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
5310 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
114764 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
345207 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
711929 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-131011 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-283587 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
11907 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12839 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11907 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12839 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
12532 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
4934 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
28718 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
18228 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
160656 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
324973 usd
BBLR Proceeds From Sale Of Fixed Assets
ProceedsFromSaleOfFixedAssets
16916 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
136322 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
301811 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-283 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-32411 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6879 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27026 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7668 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32533 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
789 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5507 usd
us-gaap Interest Paid Net
InterestPaidNet
8264 usd
us-gaap Interest Paid Net
InterestPaidNet
5385 usd
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2019-10-22
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1135368 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16791489 usd
CY2024Q2 BBLR Working Capital
WorkingCapital
1955158 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_z4Hk9G7D2m17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_z5uodOXG0XKi">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex; consequently, results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2672 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1168 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2672 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1168 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1110289 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1449049 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1110289 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1449049 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
6367 usd
CY2024Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
19315 usd
CY2023Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
39116 usd
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zWahNudoq4Z9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zJMtobbi03bc">Common Stock Purchase Warrants and Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5742236 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5742236 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5742236 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5742236 shares
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
19801 usd
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
2531 usd
CY2024Q2 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.2649 pure
CY2023Q2 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.2649 pure
CY2023Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.2731 pure
CY2024Q2 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.2651 pure
CY2023Q2 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.2521 pure
CY2023Q4 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.2441 pure
CY2024Q2 us-gaap Deposit Assets
DepositAssets
200 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
200 usd
CY2023Q4 BBLR Research And Development Other Receivables
ResearchAndDevelopmentOtherReceivables
80205 usd
CY2024Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
5585 usd
CY2023Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
7098 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
5785 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
87503 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25948 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
89482 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25047 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58180 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
901 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31302 usd
us-gaap Depreciation
Depreciation
3958 usd
us-gaap Depreciation
Depreciation
6384 usd
CY2024Q2 us-gaap Depreciation
Depreciation
2513 usd
CY2023Q2 us-gaap Depreciation
Depreciation
3106 usd
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
9317 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
9317 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3410094 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3419922 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2300706 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1963294 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1109388 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1456628 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
357176 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
116125 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51699 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
56521 usd
CY2024Q2 BBLR Director Fees
DirectorFees
150000 usd
CY2023Q4 BBLR Director Fees
DirectorFees
90000 usd
CY2024Q2 BBLR Dividends Payable
DividendsPayable
108360 usd
CY2023Q4 BBLR Dividends Payable
DividendsPayable
65016 usd
CY2024Q2 BBLR Other Accred Liabilities
OtherAccredLiabilities
84312 usd
CY2023Q4 BBLR Other Accred Liabilities
OtherAccredLiabilities
76945 usd
CY2024Q2 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
166986 usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
166986 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
822932 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
544060 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1332590 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
943007 usd
CY2024Q2 BBLR Loan Payable Related Party Current
LoanPayableRelatedPartyCurrent
285730 usd
CY2023Q4 BBLR Loan Payable Related Party Current
LoanPayableRelatedPartyCurrent
158248 usd
CY2024Q2 BBLR Loan Payable Related Party Non Current
LoanPayableRelatedPartyNonCurrent
549079 usd
CY2023Q4 BBLR Loan Payable Related Party Non Current
LoanPayableRelatedPartyNonCurrent
552639 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
434089
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
549079 usd
CY2022Q3 BBLR Derivative Loss On Contract
DerivativeLossOnContract
28043 usd
CY2022Q3 us-gaap Gain Loss On Securitization Of Financial Assets
GainLossOnSecuritizationOfFinancialAssets
95768 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159690447 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159690447 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159690447 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159690447 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2538101 shares
CY2023Q4 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2023 BBLR Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M23D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2538101 shares
CY2024Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.32
BBLR Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y8M23D
CY2024Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
2538101 shares
CY2024Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
0.32
BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercisable Weighted Average Remaining Contractual Term1
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExercisableWeightedAverageRemainingContractualTerm1
P2Y8M23D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2538101 shares
BBLR Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm
P2Y8M23D
CY2024Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2024Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
2538101 shares
CY2024Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
0.32
CY2023Q2 BBLR Option Vest Description
OptionVestDescription
Company granted executives, management, and a non-executive director options to purchase our common stock as compensation for time served. The Board of Directors determines the terms of the stock option grants, which are consistent with our 2022 Equity Incentive Plan.
CY2023Q2 BBLR Option Grant Description
OptionGrantDescription
Our stock option grant general policy is that options vest 40% after 90 days of service, and the remaining options vest monthly over two years. The maximum term is ten years.
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14400000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.1560
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14400000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.1560
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11544000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0430 pure
CY2024Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Annual Forfeiture
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeiture
0 pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
4368000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1512000 shares
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2856000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14400000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11544000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M10D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y6M10D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.1518
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
217980 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
978410 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
108990 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
978410 usd
CY2024Q2 BBLR Unrecognized Compensation Liability Current
UnrecognizedCompensationLiabilityCurrent
408713 usd

Files In Submission

Name View Source Status
0001493152-24-031989-index-headers.html Edgar Link pending
0001493152-24-031989-index.html Edgar Link pending
0001493152-24-031989.txt Edgar Link pending
0001493152-24-031989-xbrl.zip Edgar Link pending
bblr-20240630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
bblr-20240630_def.xml Edgar Link unprocessable
bblr-20240630_lab.xml Edgar Link unprocessable
bblr-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bblr-20240630_cal.xml Edgar Link unprocessable